Search the Newsreel

Arrow Electronics expands IBM distribution to seven countries

Arrow Electronics has announced an expansion of its IBM distribution coverage to include seven additional European countries: Bulgaria, Croatia, the Czech Republic, Germany, Slovakia, Slovenia, and Ukraine. This move strengthens Arrow's long-standing relationship with IBM, providing channel partners in these nations with access to …

Dermata Therapeutics raises $3.4 million in private placement

Dermata Therapeutics (NASDAQ:DRMA) has announced a private placement offering expected to generate approximately $3.4 million in gross proceeds. The offering includes common stock or pre-funded warrants, along with series E and F warrants, priced at $1.46 per share. Company insiders are also participating, and …

Arrow Electronics adds seven countries to distribution coverage with IBM

CENTENNIAL, Colo., August 17, 2026--(BUSINESS WIRE)--Arrow Electronics has expanded its IBM distribution coverage to seven additional countries. The expansion enables Arrow to distribute IBM solutions to channel partners in Bulgaria, Croatia, the Czech Republic, Germany, Slovakia, Slovenia and Ukraine. This will enable channel partner …

Third Coast Bancshares (NASDAQ:TCBX) Reaches New 52-Week High - Still a Buy?

Third Coast Bancshares (NASDAQ: TCBX) recently hit a new 52-week high of $46.25, trading above its 50-day and 200-day moving averages. Despite a "Moderate Buy" consensus rating from analysts, the average price target of $46.00 suggests limited upside. The company has also authorized a …

PTGX Maintained by BMO Capital -- Price Target Raised to $178

BMO Capital has maintained its 'Outperform' rating for Protagonist Therapeutics Inc (PTGX) and significantly raised its price target from $112.00 to $178.00. Despite this positive analyst sentiment, GuruFocus indicates PTGX is 76.8% overvalued with a GF Value™ of $87.75, and its GF Score™ of …

SERV Stock Rallies On Grubhub Partnership, DoorDash Deal Expansion — CEO Calls It 'Clearest Signal Yet Of Where We're Headed'

Sical Logistics turns profitable in Q1FY26 with ₹212.1M net profit

Why Medicenna Therapeutics Corp stock surged yesterday

STMicroelectronics (STM) lifts treasury stock to 18.8M shares

STMicroelectronics (STM) announced that it repurchased 115,000 ordinary shares between August 10 and August 14, 2026, as part of its ongoing share buyback program. These shares were bought on Euronext Paris for a total of EUR 5,518,320.50 at a weighted average price of EUR …

CS Disco (NYSE: LAW) insider to sell 8,900 shares via Morgan Stanley

CS Disco, Inc. insider Karen Herckis has filed a notice to sell 8,900 shares of common stock through Morgan Stanley Smith Barney LLC, valued at $35,600. This sale follows her acquisition of 15,779 shares on August 16, 2026, through restricted stock unit vesting and …

CS Disco (NYSE: LAW) insider Melanie Antoon plans 8,900-share sale

CS Disco insider Melanie Antoon has filed to sell 8,900 shares of common stock through Morgan Stanley Smith Barney LLC on or after August 17, 2026. This planned sale follows the vesting of 20,538 Restricted Stock Units (RSUs) on August 16, 2026, which were …

CS Disco (NYSE: LAW) insider lines up 7,200-share sale

An insider at CS Disco, Inc. (NYSE: LAW), Susan Garcia, has announced a planned sale of 7,200 shares of common stock, valued at $28,800, through Morgan Stanley Smith Barney LLC Executive Financial Services, with an expected sale date of August 17, 2026. This disclosure …

Will XPO’s New Chief Legal Officer Reframe Its Technology-Driven Efficiency Story (XPO)?

XPO, Inc. announced the appointment of Jonas Svedlund as its new chief legal officer, bringing extensive legal experience to the company. His arrival is expected to influence XPO's investment narrative, particularly concerning its technology-driven efficiency and how it navigates regulatory, contractual, and technology issues …

Focus Partners Advisor Solutions LLC Invests $1.34 Million in Arrow Electronics, Inc. $ARW

Focus Partners Advisor Solutions LLC has invested approximately $1.34 million in Arrow Electronics, acquiring 6,291 shares of the technology company in the second quarter. Arrow Electronics recently surpassed quarterly earnings and revenue expectations, reporting $5.45 EPS and $9.99 billion in revenue, and also authorized …

Stifel reiterates Tango Therapeutics stock rating with $40 target

Stifel has reaffirmed its Buy rating for Tango Therapeutics Inc. (NASDAQ:TNGX) with a price target of $40.00, despite the stock appearing overvalued relative to its Fair Value estimate. The firm anticipates positive longer follow-up data from an upcoming ESMO 2026 presentation regarding the company's …

Huntington Bancshares scores Overweight rating at Wells Fargo (HBAN:NASDAQ)

Wells Fargo initiated coverage of Huntington Bancshares (HBAN) with an Overweight rating, citing potential growth from recent acquisitions. The bank's strong focus on commercial loans is expected to benefit from increasing industrial growth.

Crocs gives its iconic crocodile a life of its own with new mascot Niles

Crocs has introduced Niles, an official mascot based on its iconic crocodile silhouette, as a new character-led storytelling platform. Niles, described as funny and optimistic, will engage consumers through social content, episodic videos, live appearances, and future brand extensions, aiming to build deeper emotional …

Protagonist Therapeutics (NASDAQ:PTGX) Stock Price Expected to Rise, BMO Capital Markets Analyst Says

Ericsson (NASDAQ: ERIC) adds 2.5M shares to treasury in SEK 15B buyback

Ericsson reported repurchasing 2.5 million Class B shares between August 10 and 14, 2026, for a total of SEK 241,754,225, as part of its SEK 15 billion share buyback program. The weighted average price for these transactions was SEK 96.7017 per share. Following these …

Interlink Electronics Will Participate in Lytham's Investor Summit—When?

Interlink Electronics (Nasdaq: LINK) announced it will participate in the virtual Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026. The company's webcast presentation is scheduled for 11:30 a.m. ET, and investors can access it via the Lytham Partners conference homepage, …

Canaccord Genuity Group Issues Positive Forecast for Cardiol Therapeutics (NASDAQ:CRDL) Stock Price

HomeTrust Bancshares, Inc. Expands into Attractive Virginia Markets Through Acquisition of Blue Ridge Bankshares, Inc.

Fulcrum (NASDAQ: FULC) investors get cash but small stake post‑Slate deal

Jasper Therapeutics beats Q2 expectations but shares fall after results

Company report on computer screen ©Adobe Stock Images Jasper Therapeutics Inc. (NASDAQ:JSPR) reported better-than-expected second-quarter 2026 results on Monday, although shares of the clinical-stage biotechnology company fell 4.24% in pre-market trading following the announcement. For the quarter ended June 30, 2026, Jasper recorded an …

Form 8K Dermata Therapeutics Inc For: 17 August By Investing.com

The article reports that Dermata Therapeutics Inc. filed a Form 8K on August 17th. This filing is a significant event for investors as it typically discloses important unscheduled material events or corporate changes that shareholders should be aware of. The article provides only this …

Uber Eats slump hits Serve Robotics (NASDAQ: SERV) as it expands robots

Serve Robotics (NASDAQ: SERV) reported a decline in Q2 2026 revenue and anticipates reduced demand in the second half of 2026 due to lower-than-expected delivery volume through its Uber Eats partnership. Despite this, the company announced a significant expansion, including a new partnership with …

Serve Robotics partners with Grubhub in robot delivery expansion push

By Deborah Mary Sophia Aug 17 (Reuters) - Serve Robotics said on Monday it is partnering with Grubhub to fulfill orders on the food delivery ‌platform using its sidewalk delivery robots, tapping a new marketplace days after ‌its years-long tie-up with Uber Eats fell …

STMicroelectronics announces status of common share repurchase program

STMicroelectronics International NV STMicroelectronics announces status of common share repurchase program Disclosure of Transactions in Own Shares – Period from August 10, 2026 to August 14, 2026 AMSTERDAM – August 17, 2026 -- STMicroelectronics N.V. (the "Company" or "STMicroelectronics"), a global semiconductor leader serving …

PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026

PROCEPT BioRobotics SAN JOSE, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the "Company") (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced members of management will present and host investor meetings …

Samsung and Idomoo Partner To Launch Lucas AI Video Creation App for Samsung VXT

Lucas allows businesses to create studio-quality, on-brand videos in minutes and instantly deploy them to a range of digital displays. NEW YORK, August 17, 2026--(BUSINESS WIRE)--Idomoo's Lucas AI Video Agent has just launched on Samsung VXT, giving businesses the ability to generate fully produced, …

Sedemac Mechatronics posts 61% revenue growth in FY26; AGM set for September

Capricor Therapeutics (CAPR) Could Be 89% Undervalued Following Deramiocel And Loss Concerns

Capricor Therapeutics (CAPR) is under scrutiny after reporting wider Q2 2026 losses and ongoing legal/regulatory questions regarding its Duchenne muscular dystrophy candidate, Deramiocel. Despite recent share price volatility, with jumps of 58% in one day and 73% in seven days, the stock is still …

Radiopharm schedules FDA meeting for brain imaging agent RAD101 By Investing.com

Radiopharm Theranostics has scheduled an End-of-Phase 2 meeting with the FDA for October 1, 2026, to discuss the Phase 3 trial design for its brain imaging agent, RAD101. RAD101, which has FDA Fast Track Designation, is developed to diagnose recurrent brain metastases and showed …

Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases

Radiopharm Theranostics is scheduled to meet with the U.S. FDA on October 1st, 2026, for an End-of-Phase 2 meeting to discuss the pivotal Phase 3 trial design for RAD101. This imaging agent, which targets fatty acid synthase (FASN), is being developed for the diagnosis …

A PET scan matched MRI in 93% of lesions—what comes next?

Radiopharm Theranostics has scheduled an End-of-Phase 2 meeting with the U.S. FDA for October 1, 2026, to discuss the pivotal Phase 3 trial design for RAD101, an imaging agent for recurrent brain metastases. The company's Phase 2b trial showed a 93% concordance between MRI …

AIGH Capital Management LLC Purchases Shares of 2,795,797 Kyverna Therapeutics, Inc. $KYTX

AIGH Capital Management LLC has acquired 2,795,797 shares of Kyverna Therapeutics, Inc. (NASDAQ:KYTX), valued at approximately $24.9 million, making it their 10th largest holding. Despite Kyverna beating its quarterly EPS estimates, analysts anticipate the clinical-stage biotech will remain unprofitable this year. While HC Wainwright …